Third degree AV block
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Soroush Seifirad, M.D.[3] Qasim Khurshid, M.B.B.S.[3]
Synonyms and keywords: Third degree heart block, complete heart block, CHB
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Soroush Seifirad, M.D.[3] Cafer Zorkun, M.D., Ph.D. [4]Qasim Khurshid, M.B.B.S.
Overview
Complete heart block is a disease of the cardiac electrical conduction system where there is complete dissociation of the atrial and ventricular activity because of the absence of conduction through the atrioventricular node (AVN) or His-Purkinje system. In 1894, Dr. Engelman was the first to describe in detail the phenomenon of AV interval lengthening. In 1899, Karel Frederik published a paper on irregular pulses describing the impairment of AV conduction and blockage.Complete heart block may be transient due to increased parasympathetic tone defining vagally mediated atrioventricular block or due to persistent infranodal block whether there is evidence of conduction block distal to the atrioventricular node. Normally SA node generates impulses that travel to the AV node and gets delayed there to assure that the contraction cycle in atria is complete before a contraction begins in the ventricles. From the AV node, the impulses pass through the His-Purkinje system to cause ventricular contraction. Pathological delay in the AV node is visualized on an electrocardiogram as a change in the P-R interval. These delays are known as an AV block. No impulses from the SA node get conducted to the ventricles, and this leads to a complete atrioventricular dissociation. The SA node continues to activate at a set rate, but the ventricles will activate through an escape rhythm that can be mediated by either the AV node, one of the fascicles, or by ventricular myocytes themselves. The heart rate will mostly be less than 45 to 50 beats/min, and most patients will be hemodynamically unstable. The most common cause of a complete heart block is coronary ischemia, but there are many other etiologies. The progressive degeneration of the electrical conduction system of the heart due to aging can cause a third-degree heart block. Complete heart block can be preceded by first degree AV block, second degree AV block, or bifascicular block. Acute myocardial infarction may present as a third-degree heart block. Lupus in a pregnant mother can cause congenital heart block in newborns. Maternal antibodies can cross the placenta and lead to a complete heart block during gestation. Sometimes no cause can be identified. Third-degree heart block should not be confused with high-grade AV block which is a second-degree block with a very slow ventricular rate with occasional AV conduction, or AV Dissociation defining to indicate the occurrence of independent atrial and ventricular contractions caused by entities other than third-degree heart block.AV blocks are fairly common however, third-degree AV block is relatively rare. The incidence in the general population appears to be low, approximately 20 to 40 in 100,000 individuals in the United States. Given the etiology of the disease, the incidence among the apparently healthy and presumptively asymptomatic is even lower at approximately 1 in 100,000. Common risk factors associated atioventricular block include older age, male sex, history of myocardial infarction, history of congestive heart disease, high systolic blood pressure, increased fasting blood glucose level.Transthoracic echocardiography may be helpful in the diagnosis of the underlying diseases that tend to third-degree AV block. Echocardiography might show shreds of evidence in favor of cardiomyopathies or valvular heart diseases. In particular case scenarios, transesophageal echocardiography is warranted and may help to diagnose etiologies such as valvular ring abscess. Furthermore, the left ventricular function can be determined using an echo and provide pieces of evidence in favor of the placement of a pacemaker or defibrillator. . Common indications for echocardiography in suspicion of cardiac origin of bradycardia or conduction disorder may include syncope, lightheadedness/presyncope, symptoms related to aortic stenosis, hypertrophic cardiomyopathy, heart failure.There are no x-ray findings associated with third-degree AV block. However, a chest x-ray may be helpful in the diagnosis of complications of third degree AV block such as pulmonary edema. Additionally, a chest x-ray may be helpful in the diagnosis of the underlying disease tend to third degree AV block, or in the diagnosis of the other complications of that disorder which may include cardiomegaly and hilar adenopathy. CT scan may be helpful in the diagnosis of cardiac and chest abnormalities related to the underlying organic disease in those with third-degree AV block. Cardiac MRI may be helpful in selected patients to identify the underlying structural heart disease associated conduction disturbance such as sarcoidosis, hemochromatosis, and amyloidosis. Nuclear imaging techniques might rarely be used and may be helpful in the diagnosis of complications of third-degree AV block or provide shreds of evidence in favor of the underlying disease in those with complete heart block. Ambulatory monitoring is warranted in cases of possible transient heart block, or some other bradyarrhythmias that might be mistaken with third-degree AV block. Worsening atrioventricular block with isoproterenol and atropine may be suggestive of infranodal block. Improvement of atrioventricular conduction with carotid sinus massage may be observed in patients with infranodal atrioventric-ular block. The management of third-degree AV block depends on the severity of signs, symptoms, and the underlying cause. In symptomatic patients and with hemodynamic distress, pharmacological therapy should be initiated immediately to increase heart rate and cardiac output. Most of the patients who do not respond to pharmacologic therapy require a temporary pacemaker. After stabilizing the patients, assessment and treatment of potentially reversible causes should be done. Some patients without reversible cause or unidentified etiology require a permanent pacemaker. Cardiac pacemakers are effective treatments for a variety of cardiac conduction abnormalities and can reestablish adequate circulation by generating appropriate heart rate and cardiac response. Two main factors guide the majority of decisions regarding permanent pacemaker insertion. First is the association of symptoms with arrhythmia, and second is the potential for progression of the rhythm disturbance. Symptoms related to atrioventricular block are determining factor of placing permanent pacemaker, regardless of the level of atrioventricular block. Permanent pacemaker is warranted if the site of atrioventricular block is Infranodal, regardless of the presence or absence of symptoms. Temporary transvenous pacing is used to provide hemodynamic support or back-up pacing to prevent asystole. If atrioventricular block seems to be irreversible, it is better to proceed directly with permanent pacemaker implantation. Patients with renal insufficiency, potassium electrolyte disturbances, and dehydration are predisposed to develop digoxin toxicity. Careful monitoring of electrolytes, drug levels, and renal function is essential in patients on chronic digoxin therapy. These patients should be carefully monitored for heart blocks. There is no secondary prevention.
Historical Perspective
In 1894, Dr. Engelman was the first to describe the phenomenon of AV interval lengthening in detail. In 1899, Karel Frederik published a paper on irregular pulses describing AV conduction and blockage impairment. 1906 Einthiven was the first to present a presentation of normal and abnormal electrocardiograms recorded with a string galvanometer. Dr. Ashmar in 1925 studied and described in detail these blocked impulses and their impact on the conduction in the muscle of the heart. In 1952 Dr. Paul Zoll developed the first temporary transcutaneous pacing.
Classification
Complete heart block may be transient due to increased parasympathetic tone defining vagally mediated atrioventricular block or due to infranodal block whether there is evidence of conduction block distal to the atrioventricular node.
Pathophysiology
Normally SA node generates impulses that travel to the AV node and gets delayed there to assure that the contraction cycle in atria is complete before a contraction begins in the ventricles. From the AV node, the impulses pass through the His-Purkinje system to cause ventricular contraction. Pathological delay in the AV node is visualized on an electrocardiogram as a change in the P-R interval. These delays are known as an AV block. No impulses from the SA node get conducted to the ventricles, and this leads to a complete atrioventricular dissociation. The SA node continues to activate at a set rate, but the ventricles will activate through an escape rhythm that can be mediated by either the AV node, one of the fascicles, or by ventricular myocytes themselves. The heart rate will mostly be less than 45 to 50 beats/min, and most patients will be hemodynamically unstable.
Causes
The most common cause of a complete heart block is coronary ischemia, but there are many other etiologies. The progressive degeneration of the electrical conduction system of the heart due to aging can cause a third-degree heart block. Complete heart block can be preceded by first degree AV block, second degree AV block, or bifascicular block. Acute myocardial infarction may present as a third-degree heart block. Lupus in a pregnant mother can cause congenital heart block in newborns. Maternal antibodies can cross the placenta and lead to a complete heart block during gestation. Sometimes no cause can be identified.
Differentiating Third degree AV block from other Diseases
Third-degree heart block should not be confused with high-grade AV block which is a second-degree block with a very slow ventricular rate with occasional AV conduction, or AV Dissociation defining to indicate the occurrence of independent atrial and ventricular contractions caused by entities other than third-degree heart block.
Epidemiology and Demographics
AV blocks are fairly common however, third-degree AV block is relatively rare. The incidence in the general population appears to be low, approximately 20 to 40 in 100,000 individuals in the United States. Given the etiology of the disease, the incidence among the apparently healthy and presumptively asymptomatic is even lower at approximately 1 in 100,000.
Risk Factors
Common risk factors associated atioventricular block include older age, male sex, history of myocardial infarction, history of congestive heart disease, high systolic blood pressure, increased fasting blood glucose level.
Screening
There is insufficient evidence to recommend routine screening for third degree AV block. However, screening for congenital AV block is recommended
Natural History, Complications and Prognosis
Spontaneous recovery from third-degree heart block is not common. Untreated third-degree heart block is associated with high mortality, which appears to occur as a consequence of the complications of decreased perfusion as a consequence of bradycardia and decreased cardiac output. Common complications of third-degree AV block include syncope, musculoskeletal injuries due to falling, and sudden cardiac death. The prognosis of the third-degree heart block is most likely dependent on the patient‘s underlying disease burden and severity of the clinical presentation on arrival. Patients treated with permanent pacemaker have an good prognosis.
Diagnosis
Diagnostic Study of Choice
A 12-lead Electrocardiography (ECG) is the gold standard test for the diagnosis of third degree AV block.
History and Symptoms
Patients with third-degree AV block typically experience a low blood pressure, decreased heart rate, and poor circulation. Some patients with complete heart block may experience difficulties in doing exercise, as the heart cannot react quickly to sudden changes in demand or sustain the higher heart rates required for sustained physical activity. Complete heart block associated with a slower pacemaker can result in dizziness, presyncope andsyncope.
Physical Examination
Initial triage of patients with complete heart block consists of determining symptoms, taking vital signs, and looking for evidence of hemodynamic instability. Patients with complete heart block may have serve bradycardia, S3 gallop, new murmurs, peripheral edema, and hepatomegaly. Patients may have signs of hypoperfusion, such as altered mental status, lethargy, and hypotension.
Laboratory Findings
There is not any recommendation about routine laboratory tests in patients presented with bradycardia or conduction disorder. However, in suspicion of the underlying causes of bradycardia including sepsis, rheumatologic disorder, or thyroid disease specific tests are warranted.
Echocardiography
Transthoracic echocardiography may be helpful in the diagnosis of the underlying diseases that tend to third-degree AV block. Echocardiography might show shreds of evidence in favor of cardiomyopathies or valvular heart diseases. In particular case scenarios, transesophageal echocardiography is warranted and may help to diagnose etiologies such as valvular ring abscess. Furthermore, the left ventricular function can be determined using an echo and provide pieces of evidence in favor of the placement of a pacemaker or defibrillator. . Common indications for echocardiography in suspicion of cardiac origin of bradycardia or conduction disorder may include syncope, lightheadedness/presyncope, symptoms related to aortic stenosis, hypertrophic cardiomyopathy, heart failure.
X-Ray
There are no x-ray findings associated with third-degree AV block. However, a chest x-ray may be helpful in the diagnosis of complications of third degree AV block such as pulmonary edema. Additionally, a chest x-ray may be helpful in the diagnosis of the underlying disease tend to third degree AV block, or in the diagnosis of the other complications of that disorder which may include cardiomegaly and hilar adenopathy.
CT scan
CT scan may be helpful in the diagnosis of cardiac and chest abnormalities related to the underlying organic disease in those with third-degree AV block.
MRI
Cardiac MRI may be helpful in selected patients to identify the underlying structural heart disease associated conduction disturbance such as sarcoidosis, hemochromatosis, and amyloidosis.
Other Imaging Findings
Determination the underlying cardiac or non-cardiac cause of bradycardia or conduction disorder has prognostic value. When the structural heart disease can not be identified by echocardiography, advanced imaging including TEE, cardiac computed tomography, cardiac MRI may be helpful in selected patients.
Other Diagnostic Studies
Ambulatory monitoring is warranted in cases of possible transient heart block, or some other bradyarrhythmias that might be mistaken with third-degree AV block. Worsening atrioventricular block with isoproterenol and atropine may be suggestive of infranodal block. Improvement of atrioventricular conduction with carotid sinus massage may be observed in patients with infranodal atrioventric-ular block.
Treatment
Medical Therapy
The management of third-degree AV block depends on the severity of signs, symptoms, and the underlying cause. In symptomatic patients and with hemodynamic distress, pharmacological therapy should be initiated immediately to increase heart rate and cardiac output. Most of the patients who do not respond to pharmacologic therapy require a temporary pacemaker. After stabilizing the patients, assessment and treatment of potentially reversible causes should be done. Some patients without reversible cause or unidentified etiology require a permanent pacemaker.
Surgery
Cardiac pacemakers are effective treatments for a variety of cardiac conduction abnormalities and can reestablish adequate circulation by generating appropriate heart rate and cardiac response. Two main factors guide the majority of decisions regarding permanent pacemaker insertion. First is the association of symptoms with arrhythmia, and second is the potential for progression of the rhythm disturbance. Symptoms related to atrioventricular block are determining factor of placing permanent pacemaker, regardless of the level of atrioventricular block. Permanent pacemaker is warranted if the site of atrioventricular block is Infranodal, regardless of the presence or absence of symptoms. Temporary transvenous pacing is used to provide hemodynamic support or back-up pacing to prevent asystole. If atrioventricular block seems to be irreversible, it is better to proceed directly with permanent pacemaker implantation.
Primary Prevention
Patients with renal insufficiency, potassium electrolyte disturbances, and dehydration are predisposed to develop digoxin toxicity. Careful monitoring of electrolytes, drug levels, and renal function is essential in patients on chronic digoxin therapy. Patients on multiple nodal agents are susceptible for the development of third-degree atrioventricular (AV) block (complete heart block). These patients should be carefully monitored for heart blocks.
Secondary Prevention
There is no secondary prevention.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2] Aditya Ganti M.B.B.S. [3] Qasim Khurshid, M.B.B.S [4]
Overview
In 1894, Dr. Engelman was the first to describe in detail the phenomenon of AV interval lengthening. In 1899, Karel Frederik published a paper on irregular pulses describing impairment of AV conduction and blockage. 1906 Einthiven was the first to present a presentation of normal and abnormal electrocardiograms recorded with string galvanometer. Dr. Ashmar in 1925 studied and described in detail this blocked impulses and their impact on the conduction in the muscle of the heart. In 1952 Dr. Paul Zoll developed first temporary transcutaneous pacing.
Historical Perspective
- In 1895, Willem Einthoven invented the first practical electrocardiogram.
- In 1894, Dr. Engelmann described a phenomenon of AV interval lengthening.
- In 1899, Karel Frederik Wenckebach published a paper “On the analysis of irregular pulses”
- Described the impairment of AV conduction leading to progressive lengthening and blockage of AV conduction in frogs.
- This was later called Wenckebach block (Mobitz type I) or Wenckebach phenomenon.
- In 1906, Einthoven was the first to organize a presentation of normal and abnormal electrocardiograms recorded with help of string galvanometer
- In 1925, Dr. Ashmar further studied this blocked impulses and their impact on the conduction in the muscle of the heart.
- In 1930, Sanders was the first to describe infarction of the right ventricle.
- In 1949, Norman Jeff Holter developed a first Holter monitor which was a 75 pound backpack that can record the ECG of the wearer and transmit the signal.
Landmark Events in the Development of Treatment Strategies
- Paul Zoll in 1952: invented temporary transcutaneous cardiac pacing.
- Seymour Furman in 1958: developed temporary endocardial approach
- Åke Senningm and Elmqvist in 1958: developed Implantable Pacemakers.[2]
References
- ↑ LANGENDORF R (1948). “Concealed A-V conduction; the effect of blocked impulses on the formation and conduction of subsequent impulses”. Am Heart J. 35 (4): 542–52. doi:10.1016/0002-8703(48)90641-3. PMID 18907667.
- ↑ van Hemel NM, van der Wall EE (2008). “8 October 1958, D Day for the implantable pacemaker”. Neth Heart J. 16 (Suppl 1): S3–4. PMC 2572009. PMID 18958267.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Soroush Seifirad, M.D.[3] Cafer Zorkun, M.D., Ph.D. [4] Qasim Khurshid, M.B.B.S [4]
Overview
Third-degree or complete atrioventricular block suggests no conduction at all from atria to ventricles and may be paroxysmal or persistent and is usually associated with either a junctional or ventricular escape rhythm. Complete atrioventricular block may be identified in the setting of atrial fibrillation when the ventricular response is slow (<50 bpm) and regular. However, junctional rhythm in the setting of atrioventricular block may be present.
Classification
| Term | Classification | Definition | |
|---|---|---|---|
| Atrioventricular block | First-degree atrioventricular block |
| |
| Second-degree AV block |
| ||
| Third-degree AV block (complete heart block) |
|
References
- ↑ Kusumoto, Fred M.; Schoenfeld, Mark H.; Barrett, Coletta; Edgerton, James R.; Ellenbogen, Kenneth A.; Gold, Michael R.; Goldschlager, Nora F.; Hamilton, Robert M.; Joglar, José A.; Kim, Robert J.; Lee, Richard; Marine, Joseph E.; McLeod, Christopher J.; Oken, Keith R.; Patton, Kristen K.; Pellegrini, Cara N.; Selzman, Kimberly A.; Thompson, Annemarie; Varosy, Paul D. (2019). “2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society”. Circulation. 140 (8). doi:10.1161/CIR.0000000000000628. ISSN 0009-7322.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2] Cafer Zorkun, M.D., Ph.D. [3]; Raviteja Guddeti, M.B.B.S. [4] Qasim Khurshid, M.B.B.S[5]
Overview
Normally SA node generates impulses that travel to the AV node and gets delayed there to assure that the contraction cycle in atria is complete before a contraction begins in the ventricles. From the AV node, the impulses pass through the His-Purkinje system to cause ventricular contraction. Pathological delay in the AV node is visualized on an electrocardiogram as a change in the P-R interval. These delays are known as an AV block. No impulses from the SA node get conducted to the ventricles, and this leads to a complete atrioventricular dissociation. The SA node continues to activate at a set rate, but the ventricles will activate through an escape rhythm that can be mediated by either the AV node, one of the fascicles, or by ventricular myocytes themselves. The heart rate will mostly be less than 45 to 50 beats/min, and most patients will be hemodynamically unstable.
Pathophysiology
Physiology
The normal physiology of the electrical activity of the heart can be understood as follows:
- Normal impulse is generated in the sinoatrial node (SAN).
- Electrical pulse then travels through the atrium.
- P wave is recorded in the ECG
- Wave reaches the atrioventricular node (AVN).
- Atrioventricular node later conducts the impulse to the His bundle.
- The bundle of his again gets divided into the right and left bundles, ultimately conducting this impulse to the ventricles.
- PR segment is recorded (atrial, AVN, and His-Purkinje conduction)
- Complete heart block occurs when complete block of this conduction occurs.
Pathogenesis
- In complete heart block, because the impulse is blocked, an accessory pacemaker below the level of the block will typically activate the ventricles; this is known as an escape rhythm.
- When there is no electrical connection between atria and ventricles, two independent pacemakers will generate impulse independent of SA node. EKG will show two rhythms independent of each other
- One independent pacemaker will activate the atria and create the P waves with typically with a regular P to P interval.
- The second independent pacemaker in ventricles will activate the ventricles and produce the QRS complex with typically regular R to R interval.
- The PR interval will be a variable that is a hallmark feature of complete heart block and with no apparent relationship between P waves and QRS complexes.
- Morphology of the QRS complex helps in determining the location at which the escape rhythms are occurring.
- If the site of complete heart block is at the level of the AV node, two-thirds of the escape rhythms have a narrow QRS complex.
- If the site of block is the His bundle, typically a narrow QRS complex is seen.
- Patients with trifascicular block have a wide QRS complex (seen in 80% of the cases).
- In short, if escape rhythm has a narrow QRS complex, the level of the block can be either AV node or His bundle, and if the QRS duration is prolonged, the level of block is in the fascicles or bundle branches.
- Block at the level of the AV node gives rise to an escape rhythm that generally arises from a junctional pacemaker with a heart rate of 45-60 beats per minute. Such patients are hemodynamically stable.
- Escape rhythms arise from the His bundle or bundle branch Purkinje system at rates slower than 45 beats per minute when the block is below the AV node.
- These patients are hemodynamically unstable, and their heart rate is unresponsive to exercise and atropine.
Genetics
- Third degree AV block is the result of ischemia in majority of the patients.
- In certain disease like lyme disease also we might observe AV block.
- Nevertheless, there are some rare cases of idiopathic AV block
- In those cases, third degree AV block is transmitted in autosomal dominant pattern most of the time.
| Genes involved in the pathogenesis of third degree AV block | |
|---|---|
| AV CONDUCTION DISEASE AND CONGENITAL CARDIAC MALFORMATIONS |
|
| AV CONDUCTION DISEASE, VENTRICULAR HYPERTROPHY, AND WOLFF-PARKINSON-WHITE SYNDROME |
|
| AV CONDUCTION DISEASE : A CHANNELOPATHY |
|
Associated Conditions
Conditions associated with third degree AV block include:
- Ischemic heart disease (Major)
- Congenital cardiac malformations
- Ventricular hypertrophy
- WPW syndrome
- Chenlopatioes such as Andersen-Tawil syndrome
AV dissociation
AV dissociation is defined as:
- Independent atrial and ventricular activation either due to complete heart block or as a result of physiologic refractoriness of conduction tissue.
- It also may develop when the atrial/sinus rate is slower than the ventricular rate (accelerated junctional tachycardia or VT).
- This is called isorhythmic AV dissociation.
- Acceleration of the atrial/sinus rate with either maneuvers or medications will result in restoration of normal conduction.
References
- ↑ Benson DW (2004). “Genetics of atrioventricular conduction disease in humans”. Anat Rec A Discov Mol Cell Evol Biol. 280 (2): 934–9. doi:10.1002/ar.a.20099. PMID 15372490.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2] Cafer Zorkun, M.D., Ph.D. [3]; Raviteja Guddeti, M.B.B.S. [4]; Hilda Mahmoudi M.D., M.P.H.[5]
Overview
Atrioventricular block can be due to congenital or acquired causes. The latter are much more common form and include infectious, inflammatory, degenerative, ischemic, and iatrogenic causes. The degenerative cause are associated with increased age, chronic hypertension, and diabetes mellitus. Infectious cause of atrioventricular block such as lyme carditis may be reversible with medical therapy. Another reversible cause of atrioventricular block including ischemic inferior wall MI due to vagotonic effect should be considered.
Causes
The causes of third degree heart block can be broadly divided into acquired and congenital. Many of the acquired causes are the result of Infiltration, fibrosis, or loss of connection in the heart conduction system that can tend to develop heart block.
Congenital form of complete heart block
- Usually occurs at AVN. Patients are intially asymptomatic but may symptomatic during exertion. Mostly associated with maternal antibodies to SS-A (Ro) and SS-B (La).
Common causes of acquired AV block are as follows
- Ischemia or infarction:
- AV node (AVN) block associated with inferior wall myocardial infarction (MI)
- His-Purkinje block associated with anterior wall MI
- Drugs:
- Most of the antiarrhythmics like quinidine, , disopyramide,procainamide flecainide, encainide, beta-blockers propafenone, , amiodarone, sotalol, dofetilide, ibutilide, calcium channel blockers, Digoxin and other cardiac glycosides.
- Infectious disease:
- Lyme borreliosis (mostly in endemic areas)
- Myocarditis
- Aspergillus myocarditis
- Chagas disease: Trypanosoma cruzi infection
- Varicella-zoster virus infection
- Valve ring abscess
- Degenerative diseases:
- Lenègre disease (sclerodegenerative process involving only the conduction system)
- Lev’s disease (calcification of the conduction system and valves)
- Noncompaction cardiomyopathy
- Nail-patella syndrome
- Mitochondrial myopathy
- Rheumatic diseases:
- Infiltrative pathologies:
- Neuromuscular disorders:
- Metabolic abnormality:
- Toxins:
- Grayanotoxin:“Mad” honey
- Natural cardiac glycosides such as oleandrin
- Bradycardia-related block
- Iatrogenic heart block
- Aortic valve surgery
- Septal alcohol ablation
- Percutaneous coronary intervention (PCI) to the left anterior descending artery
- Ablation of the slow or fast pathway of the AVN
- Ablation of accessory pathways near AVN
Life Threatening Causes
Third degree heart block is a life-threatening condition and must be treated as such irrespective of the causes. Life-threatening conditions can result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Acute rheumatic fever
- Coronary ischemia
- Myocardial infarction [2]
- Systemic lupus erythematosus
- Valvular heart disease
Medications inducing bradycardia or conduction disorder
| Anti-hypertensive | Anti-arrhythmic | Psychoactive | Other |
|---|---|---|---|
| • Beta-Adrenergic Receptor Blockers
• Non-dihydropyridine calcium channel blockers |
• Adenosine .
• Sotalol |
• Donepezil
• Lithium • Opioid analgesics • Phenothiazine antiemetics and antipsychotics • Selective Serotonin Reuptake Inhibitors • Tricyclic Antidepressants |
• Anesthetic Drugs (propofol)
• Cannabis • Digoxin • Muscle relaxants (e.g. succinylcholine) |
Causes by Organ System
Third degree AV block causes developed by WikiDoc.org
Causes in Alphabetical Order
References
- ↑ Ozcan, Kazim Serhan; Osmonov, Damirbek; Erdinler, Izzet; Altay, Servet; Yildirim, Ersin; Turkkan, Ceyhan; Hasdemir, Hakan; Cakmak, Nazmiye; Alper, Ahmet Taha; Satilmis, Seckin; Gurkan, Kadir (2012). “Atrioventricular block in patients with thyroid dysfunction: Prognosis after treatment with hormone supplementation or antithyroid medication”. Journal of Cardiology. 60 (4): 327–332. doi:10.1016/j.jjcc.2012.05.012. ISSN 0914-5087.
- ↑ 2.0 2.1 2.2 Malla RR, Sayami A (2007). “In hospital complications and mortality of patients of inferior wall myocardial infarction with right ventricular infarction”. JNMA J Nepal Med Assoc. 46 (167): 99–102. PMID 18274563.
- ↑ Invalid
<ref>tag; no text was provided for refs named:0 - ↑ 4.0 4.1 4.2 4.3 “Congenital complete atrioventricular”. Retrieved 21 August 2013. Text “block. ” ignored (help)
- ↑ 5.0 5.1 Lionakis N, Moyssakis I, Gialafos E, Dalianis N, Votteas V (2008). “Aortic dissection and third-degree atrioventricular block in a patient with a hypertensive crisis”. J Clin Hypertens (Greenwich). 10 (1): 69–72. PMID 18174773. Unknown parameter
|month=ignored (help) - ↑ 6.0 6.1 Liu R, Qiao SB, Hu FH, Yang WX, Yuan JS (2012). “[Clinical features of five patients with delayed third degree atrioventricular block after ethanol septal ablation for hypertrophic obstructive cardiomyopathy]”. Zhonghua Xin Xue Guan Bing Za Zhi (in Chinese). 40 (12): 1009–11. PMID 23363714. Unknown parameter
|month=ignored (help) - ↑ 7.0 7.1 Sykes JA, Lubega J, Ezetendu C, Verma R, O’Connor B, Kalyanaraman M (2011). “Asymptomatic complete atrioventricular block in a 13-year-old girl”. Pediatr Emerg Care. 27 (11): 1081–3. doi:10.1097/PEC.0b013e3182360674. PMID 22068075. Unknown parameter
|month=ignored (help) - ↑ 8.0 8.1 Wills BK, Liu JM, Wahl M (2010). “Third-degree AV block [from extended-release diltiazem ingestion in a nine-month-old”. J Emerg Med. 38 (3): 328–31. doi:10.1016/j.jemermed.2007.10.053. PMID 18403171. Unknown parameter
|month=ignored (help) - ↑ 9.0 9.1 Amasyalı B, Barçın C, Kılıç A (2011). “[Supra-His complete atrioventricular block in a patient with subclinical hyperthyroidism]”. Turk Kardiyol Dern Ars (in Turkish). 39 (8): 693–6. PMID 22257810. Unknown parameter
|month=ignored (help) - ↑ 10.0 10.1 Maleki AR, Nikyar B, Hosseini SM (2012). “Third-Degree Heart Block in Thalassemia major: A Case Report”. Iran J Pediatr. 22 (2): 260–4. PMC 3446065. PMID 23056897. Unknown parameter
|month=ignored (help) - ↑ 11.0 11.1 Bhattacharya IS, Dweck M, Francis M (2010). “Lyme carditis: a”. J R Coll Physicians Edinb. 40 (2): 121–2. doi:10.4997/JRCPE.2010.207. PMID 21125053. Text “reversible cause of complete atrioventricular block ” ignored (help); Unknown parameter
|month=ignored (help) - ↑ 12.0 12.1 Wagner V, Zima E, Gellér L, Merkely B (2010). “[Acute atrioventricular block in chronic Lyme disease]”. Orv Hetil (in Hungarian). 151 (39): 1585–90. doi:10.1556/OH.2010.28965. PMID 20840915. Unknown parameter
|month=ignored (help) - ↑ 13.0 13.1 Semmler D, Blank R, Rupprecht H (2010). “Complete AV block in Lyme carditis: an important differential diagnosis”. Clin Res Cardiol. 99 (8): 519–26. doi:10.1007/s00392-010-0152-8. PMID 20464556. Unknown parameter
|month=ignored (help) - ↑ 14.0 14.1 Frikha Z, Abid L, Abid D; et al. (2011). “Cardiac tamponade and paroxysmal third-degree atrioventricular block revealing a primary cardiac non-Hodgkin large B-cell lymphoma of the right ventricle: a case report”. J Med Case Rep. 5: 433. doi:10.1186/1752-1947-5-433. PMC 3180417. PMID 21892927.
- ↑ 15.0 15.1 Houchaymi Z, Helou S, Ballout J (2010). “[Pericardial tamponade and third-degree atrioventricular block revealing a primary cardiac lymphoma]”. Rev Med Interne (in French). 31 (11): e4–6. doi:10.1016/j.revmed.2010.01.014. PMID 20605278. Unknown parameter
|month=ignored (help) - ↑ 16.0 16.1 van Cleef AN, Schuurman MJ, Busari JO (2011). “Third-degree atrioventricular block in an adolescent following acute alcohol intoxication”. BMJ Case Rep. 2011. doi:10.1136/bcr.07.2011.4547. PMID 22679160.
- ↑ 17.0 17.1 Brvar M, Bunc M (2009). “High-degree atrioventricular block in acute ethanol poisoning: a case report”. Cases J. 2: 8559. doi:10.4076/1757-1626-2-8559. PMC 2769457. PMID 19918387.
- ↑ 18.0 18.1 Tian Z, Fang Q, Zhao DC; et al. (2010). “[The clinico-pathological manifestation of cardiac involvement in eosinophilic diseases]”. Zhonghua Nei Ke Za Zhi (in Chinese). 49 (8): 684–7. PMID 20979789. Unknown parameter
|month=ignored (help) - ↑ 19.0 19.1 Facenda-Lorenzo M, Hernández-Afonso J, Rodríguez-Esteban M, de León-Hernández JC, Grillo-Pérez JJ (2012). “Cardiac Manifestations in Myotonic Dystrophy Type 1 Patients Followed Using a Standard Protocol in a Specialized Unit”. Rev Esp Cardiol. doi:10.1016/j.recesp.2012.08.011. PMID 23194837. Unknown parameter
|month=ignored (help) - ↑ 20.0 20.1 Femenía F, Arce M, Arrieta M (2010). “[Systemic sclerosis complicated with syncope and complete AV block]”. Medicina (B Aires) (in Spanish; Castilian). 70 (5): 442–4. PMID 20920962.
- ↑ 21.0 21.1 Thakar S, Chandra P, Pednekar M, Kabalkin C, Shani J (2012). “Complete heart block following a blow on the chest by a soccer ball: a rare manifestation of commotio cordis”. Ann Noninvasive Electrocardiol. 17 (3): 280–2. doi:10.1111/j.1542-474X.2012.00518.x. PMID 22816548. Unknown parameter
|month=ignored (help) - ↑ 22.0 22.1 Portet N, Riu B, Bounes V, Minville V, Fourcade O (2012). “Left ventricular-right atrial communication with third-degree atrioventricular block after thoracic trauma”. J Emerg Med. 43 (6): e385–8. doi:10.1016/j.jemermed.2010.11.059. PMID 21621364. Unknown parameter
|month=ignored (help)
Differentiating Third degree AV block from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2] Qasim Khurshid, M.B.B.S [3]
Overview
Third degree AV block must be differentiated from Mobitz type II, Junctional rhythm, and sinus bradycardia.
Differentiating third degree AV block from other Diseases
Third-degree AV block must be differentiated from Mobitz type II, Junctional rhythm, and sinus bradycardia, Paroxysmal supraventricular tachycardia. The following table summarizes the differential diagnosis of third-degree AV block.
| Arrhythmia | Rhythm | Rate | P wave | PR Interval | QRS Complex | Response to Maneuvers | Epidemiology | Co-existing Conditions | |
|---|---|---|---|---|---|---|---|---|---|
| Atrioventricular block[1] | First degree [2][3] |
|
|
|
|
|
|
| |
| Second degree[4][5] |
|
|
|
QRS is normal but dropped as the following:
|
|
| |||
| Third degree[6][7] |
|
|
|
|
|
| |||
| Atrial Fibrillation (AFib)[8][9] |
|
|
|
|
|
|
|
| |
| Atrial Flutter[10] |
|
|
|
|
|
|
|
||
| Atrioventricular nodal reentry tachycardia (AVNRT)[11][12][13][14] |
|
|
|
|
|
|
|
||
| Multifocal Atrial Tachycardia[15][16] |
|
|
|
|
|
|
|
||
| Paroxysmal Supraventricular Tachycardia |
|
|
|
|
|
|
|
||
| Premature Atrial Contractrions (PAC)[17][18] |
|
|
|
|
|
|
|||
| Wolff-Parkinson-White Syndrome[19][20] |
|
|
|
|
|
|
|
| |
| Ventricular Fibrillation (VF)[21][22][23] |
|
|
|
|
|
|
|
| |
| Ventricular Tachycardia[24][25] |
|
|
|
|
|
|
|
| |
References
- ↑ Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ; et al. (2019). “Risk Factors Associated With Atrioventricular Block”. JAMA Netw Open. 2 (5): e194176. doi:10.1001/jamanetworkopen.2019.4176. PMC 6632153 Check
|pmc=value (help). PMID 31125096. - ↑ Barold SS (1996). “Indications for permanent cardiac pacing in first-degree AV block: class I, II, or III?”. Pacing Clin Electrophysiol. 19 (5): 747–51. doi:10.1111/j.1540-8159.1996.tb03355.x. PMID 8734740.
- ↑ Upshaw CB (2004). “Comparison of the prevalence of first-degree atrioventricular block in African-American and in Caucasian patients: an electrocardiographic study III”. J Natl Med Assoc. 96 (6): 756–60. PMC 2568382. PMID 15233485.
- ↑ Zehender M, Meinertz T, Keul J, Just H (1990). “ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance”. Am Heart J. 119 (6): 1378–91. doi:10.1016/s0002-8703(05)80189-9. PMID 2191578.
- ↑ Friedman HS, Gomes JA, Haft JI (1975). “An analysis of Wenckebach periodicity”. J Electrocardiol. 8 (4): 307–15. doi:10.1016/s0022-0736(75)80003-3. PMID 1176840.
- ↑ OSTRANDER LD, BRANDT RL, KJELSBERG MO, EPSTEIN FH (June 1965). “ELECTROCARDIOGRAPHIC FINDINGS AMONG THE ADULT POPULATION OF A TOTAL NATURAL COMMUNITY, TECUMSEH, MICHIGAN”. Circulation. 31: 888–98. doi:10.1161/01.cir.31.6.888. PMID 14297523.
- ↑ Movahed MR, Hashemzadeh M, Jamal MM (October 2005). “Increased prevalence of third-degree atrioventricular block in patients with type II diabetes mellitus”. Chest. 128 (4): 2611–4. doi:10.1378/chest.128.4.2611. PMID 16236932.
- ↑ Lankveld TA, Zeemering S, Crijns HJ, Schotten U (July 2014). “The ECG as a tool to determine atrial fibrillation complexity”. Heart. 100 (14): 1077–84. doi:10.1136/heartjnl-2013-305149. PMID 24837984.
- ↑ Harris K, Edwards D, Mant J (2012). “How can we best detect atrial fibrillation?”. J R Coll Physicians Edinb. 42 Suppl 18: 5–22. doi:10.4997/JRCPE.2012.S02. PMID 22518390.
- ↑ Cosío FG (June 2017). “Atrial Flutter, Typical and Atypical: A Review”. Arrhythm Electrophysiol Rev. 6 (2): 55–62. doi:10.15420/aer.2017.5.2. PMC 5522718. PMID 28835836.
- ↑ Katritsis DG, Josephson ME (August 2016). “Classification, Electrophysiological Features and Therapy of Atrioventricular Nodal Reentrant Tachycardia”. Arrhythm Electrophysiol Rev. 5 (2): 130–5. doi:10.15420/AER.2016.18.2. PMC 5013176. PMID 27617092.
- ↑ Letsas KP, Weber R, Siklody CH, Mihas CC, Stockinger J, Blum T, Kalusche D, Arentz T (April 2010). “Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway”. Acta Cardiol. 65 (2): 171–6. doi:10.2143/AC.65.2.2047050. PMID 20458824.
- ↑ “Atrioventricular Nodal Reentry Tachycardia (AVNRT) – StatPearls – NCBI Bookshelf”.
- ↑ Schernthaner C, Danmayr F, Strohmer B (2014). “Coexistence of atrioventricular nodal reentrant tachycardia with other forms of arrhythmias”. Med Princ Pract. 23 (6): 543–50. doi:10.1159/000365418. PMC 5586929. PMID 25196716.
- ↑ Scher DL, Arsura EL (September 1989). “Multifocal atrial tachycardia: mechanisms, clinical correlates, and treatment”. Am. Heart J. 118 (3): 574–80. doi:10.1016/0002-8703(89)90275-5. PMID 2570520.
- ↑ Goodacre S, Irons R (March 2002). “ABC of clinical electrocardiography: Atrial arrhythmias”. BMJ. 324 (7337): 594–7. doi:10.1136/bmj.324.7337.594. PMC 1122515. PMID 11884328.
- ↑ Lin CY, Lin YJ, Chen YY, Chang SL, Lo LW, Chao TF, Chung FP, Hu YF, Chong E, Cheng HM, Tuan TC, Liao JN, Chiou CW, Huang JL, Chen SA (August 2015). “Prognostic Significance of Premature Atrial Complexes Burden in Prediction of Long-Term Outcome”. J Am Heart Assoc. 4 (9): e002192. doi:10.1161/JAHA.115.002192. PMC 4599506. PMID 26316525.
- ↑ Strasburger JF, Cheulkar B, Wichman HJ (December 2007). “Perinatal arrhythmias: diagnosis and management”. Clin Perinatol. 34 (4): 627–52, vii–viii. doi:10.1016/j.clp.2007.10.002. PMC 3310372. PMID 18063110.
- ↑ Rao AL, Salerno JC, Asif IM, Drezner JA (July 2014). “Evaluation and management of wolff-Parkinson-white in athletes”. Sports Health. 6 (4): 326–32. doi:10.1177/1941738113509059. PMC 4065555. PMID 24982705.
- ↑ Rosner MH, Brady WJ, Kefer MP, Martin ML (November 1999). “Electrocardiography in the patient with the Wolff-Parkinson-White syndrome: diagnostic and initial therapeutic issues”. Am J Emerg Med. 17 (7): 705–14. doi:10.1016/s0735-6757(99)90167-5. PMID 10597097.
- ↑ Glinge C, Sattler S, Jabbari R, Tfelt-Hansen J (September 2016). “Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction”. J Geriatr Cardiol. 13 (9): 789–797. doi:10.11909/j.issn.1671-5411.2016.09.006. PMC 5122505. PMID 27899944.
- ↑ Samie FH, Jalife J (May 2001). “Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart”. Cardiovasc. Res. 50 (2): 242–50. doi:10.1016/s0008-6363(00)00289-3. PMID 11334828.
- ↑ Adabag AS, Luepker RV, Roger VL, Gersh BJ (April 2010). “Sudden cardiac death: epidemiology and risk factors”. Nat Rev Cardiol. 7 (4): 216–25. doi:10.1038/nrcardio.2010.3. PMC 5014372. PMID 20142817.
- ↑ Koplan BA, Stevenson WG (March 2009). “Ventricular tachycardia and sudden cardiac death”. Mayo Clin. Proc. 84 (3): 289–97. doi:10.1016/S0025-6196(11)61149-X. PMC 2664600. PMID 19252119.
- ↑ Levis JT (2011). “ECG Diagnosis: Monomorphic Ventricular Tachycardia”. Perm J. 15 (1): 65. doi:10.7812/tpp/10-130. PMC 3048638. PMID 21505622.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2] ; Aditya Ganti M.B.B.S. [3]
Overview
AV blocks are fairly common however, third-degree AV block is relatively rare. The incidence in the general population appears to be low, approximately 20 to 40 in 100,000 individuals in the United States. Given the etiology of the disease, the incidence among the apparently healthy and presumptively asymptomatic is even lower at approximately 1 in 100,000.
Epidemiology and Demographics
Incidence
- The incidence of third degree block in the general population appears to be low, approximately 20 per 100,000 in USA.[1][2][3]
Prevalence
- The prevalence of third degree AV block is approximately 40 per 100,000 worldwide.
Age
- Third degree AV block is more commonly associated with advancing age.
References
- ↑ OSTRANDER LD, BRANDT RL, KJELSBERG MO, EPSTEIN FH (June 1965). “ELECTROCARDIOGRAPHIC FINDINGS AMONG THE ADULT POPULATION OF A TOTAL NATURAL COMMUNITY, TECUMSEH, MICHIGAN”. Circulation. 31: 888–98. doi:10.1161/01.cir.31.6.888. PMID 14297523.
- ↑ Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P (March 2017). “Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association”. Circulation. 135 (10): e146–e603. doi:10.1161/CIR.0000000000000485. PMC 5408160. PMID 28122885.
- ↑ Movahed MR, Hashemzadeh M, Jamal MM (October 2005). “Increased prevalence of third-degree atrioventricular block in patients with type II diabetes mellitus”. Chest. 128 (4): 2611–4. doi:10.1378/chest.128.4.2611. PMID 16236932.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Soroush Seifirad, M.D.[3] Aditya Ganti M.B.B.S. [4]
Overview
Common risk factors associated atioventricular block include older age, male sex, history of myocardial infarction, history of congestive heart disease, high systolic blood pressure, increased fasting blood glucose level.
Risk Factors
- Common risk factors associated with atioventricular block include:[1]
- Older age
- Male sex
- History of myocardial infarction
- History of congestive heart disease
- High systolic blood pressure
- Increased fasting blood glucose level
- Common risk factors associated with atrioventricular block after cardiac surgery include:[2]
- Older age
- Atrial fibrillation
- Prior surgery
- Preoperative renal failure
- Active endocarditis
- Common risk factor associated with intraoperative bradycardia and hypotension in patients undergoing non-cardiac surgery include:[3]
- Age (>60-65 years of age)
- Comorbidities
- Lower heart rates (<60 bpm) or blood pressure (<110/60 mm Hg) at baseline
- Use of concomitant drugs such as beta-blockers, renin-angiotensin system blockers
- Preoperative RBBB
- Multivalve surgery , especially tricuspid valve
- Preoperative LBBB
- Preoperative PR interval >200 ms
- Prior valve surgery
- Age >70 years
- Reoperations
- Longer times of cross-clamp
- Absence of preoperative sinus rhythm
References
- ↑ Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ; et al. (2019). “Risk Factors Associated With Atrioventricular Block”. JAMA Netw Open. 2 (5): e194176. doi:10.1001/jamanetworkopen.2019.4176. PMC 6632153 Check
|pmc=value (help). PMID 31125096. - ↑ Bougioukas I, Jebran AF, Grossmann M, Friedrich M, Tirilomis T, Schoendube FA, Danner BC (January 2017). “Is there a correlation between late re-exploration after cardiac surgery and removal of epicardial pacemaker wires?”. J Cardiothorac Surg. 12 (1): 3. doi:10.1186/s13019-017-0569-5. PMC 5264443. PMID 28122567.
- ↑ Unnikrishnan D, Idris N, Varshneya N (November 2003). “Complete heart block during central venous catheter placement in a patient with pre-existing left bundle branch block”. Br J Anaesth. 91 (5): 747–9. doi:10.1093/bja/aeg242. PMID 14570803.
- ↑ Goldman BS, Hill TJ, Weisel RD, Scully HE, Mickleborough LL, Pym J, Baird RJ (May 1984). “Permanent cardiac pacing after open-heart surgery: acquired heart disease”. Pacing Clin Electrophysiol. 7 (3 Pt 1): 367–71. doi:10.1111/j.1540-8159.1984.tb04919.x. PMID 6204288.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Soroush Seifirad, M.D.[3] Aditya Ganti M.B.B.S. [4]
Overview
Ambulatory electrocardiographic monitoring is useful for finding intermittent atrioventricular block, LBBB and bifascicular block in asymptomatic patients. In patients with symptomatic atrioventricular block or bradycardia during sleep, screening about sleep apnea is recommended.
Screening
- Ambulatory electrocardiographic monitoring is useful for finding intermittent atrioventricular block, LBBB and bifascicular block in asymptomatic patients.
- In patients with symptomatic atrioventricular block or bradycardia during sleep, screening about sleep apnea is recommended.[1]
- Screening for congenital complete heart block is recommended in pregnant women with Ro/SSA antibodies.[2]
- Women with history of neonatal lupus, fetal echos are recommended weekly or every other week from week 18 to 28.
- It is unclear how often first degree heart block progresses to complete heart block, some cases my revert to normal sinus rhythm or complete heart block.
| Recommendations for screening sleep apnea in patients with bradycardia or conduction disorder |
| (Class I, Level of Evidence B): |
|
❑ Screening about sleep apnea syndrome is recommended In patients with documented or suspected bradycardia or conduction disorder during sleep |
| (Class IIa, Level of Evidence B): |
|
❑ In patients with previously PPM implantation for bradycardia or conduction disorder, screening about sleep apnea syndrome is reasonable |
| The above table adopted from 2018 AHA/ACC/HRS Guideline[3] |
|---|
References
- ↑ Kasai, Takatoshi; Floras, John S.; Bradley, T. Douglas (2012). “Sleep Apnea and Cardiovascular Disease”. Circulation. 126 (12): 1495–1510. doi:10.1161/CIRCULATIONAHA.111.070813. ISSN 0009-7322.
- ↑ Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E; et al. (2018). “The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices”. Rheumatology (Oxford). 57 (suppl_5): v9–v17. doi:10.1093/rheumatology/key141. PMC 6099126. PMID 30137589.
- ↑ Kusumoto, Fred M.; Schoenfeld, Mark H.; Barrett, Coletta; Edgerton, James R.; Ellenbogen, Kenneth A.; Gold, Michael R.; Goldschlager, Nora F.; Hamilton, Robert M.; Joglar, José A.; Kim, Robert J.; Lee, Richard; Marine, Joseph E.; McLeod, Christopher J.; Oken, Keith R.; Patton, Kristen K.; Pellegrini, Cara N.; Selzman, Kimberly A.; Thompson, Annemarie; Varosy, Paul D. (2019). “2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society”. Circulation. 140 (8). doi:10.1161/CIR.0000000000000628. ISSN 0009-7322.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2] Raviteja Guddeti, M.B.B.S. [3] ; Aditya Ganti M.B.B.S. [4]
Overview
The majority of the patients with complete heart block do not recover spontaneously. Untreated complete heart block is associated with high morbidity and mortality. Patients with complete heart blocks are prone to decreased perfusion related to symptomatic bradycardia and decreased cardiac output. Common Complications of third-degree AV block include sudden cardiac death due to asystole, syncope, and musculoskeletal injuries secondary to fall after syncope. The prognosis of the third-degree heart block is most likely dependent on the patient‘s underlying disease burden and severity of the clinical presentation on arrival. Patients treated with permanent pacemakers have an excellent prognosis.
Natural History, Complications, and Prognosis
Natural History
- Spontaneous recovery from third-degree heart block is very rare.
- The estimated overall mortality of non-paced patients with isolated AV block is 8%–16% in infants and 4%–8% in children and adults.[1][2]
- If left untreated, third-degree heart block is associated with high mortality which appears to occur as a consequence of the complications of prematurity and bradycardia owing to the delayed initiation of pacing therapy.
Complications
- Patients with complete heart block are susceptible to hypotension related to decreased cardiac output and bradycardia.[3]
- Patients with hemodynamic instability may be unable to protect their airway due to altered mental status leading to an aspiration that has high morbidity and mortality.
- Complications related to pace maker implantation include malposition or dislodgement of a pacemaker leads and cardiac perforation.
- Common complications of third degree AV block include:
- Sudden cardiac death due to asystole
- Syncope
- Musculoskeletal injuries secondary to fall after syncope.
- Cardiovascular collapse
- Hypotension
- Stokes-Adams syndrome
- Ventricular tachycardia[4][5]
- Ventricular fibrillation
- Worsening of heart failure
- Worsening of angina
- Death
Prognosis
- The prognosis of third degree heart block is most likely dependent on the patient‘s underlying disease burden and severity of the clinical presentation on arrival.[6]
- Complete heart block is sometimes reversible in settings such as acute MI by restoring coronary perfusion and in conditions such as Lymes disease by treatment with antibiotics.[7]
- Patients treated with permanent pacemaker have an excellent prognosis.
- Patients with complete heart block due to acute myocardial infarction are at a greater risk for sudden cardiac death.
References
- ↑ Proclemer A, Zecchin M, D’Onofrio A, Ricci RP, Boriani G, Rebellato L, Ghidina M, Bianco G, Bernardelli E, Miconi A, Zorzin AF, Gregori D (March 2019). “[The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing – Annual report 2017]”. G Ital Cardiol (Rome) (in Italian). 20 (3): 136–148. doi:10.1714/3108.30963. PMID 30821295.
- ↑ Merchant FM, Hoskins MH, Musat DL, Prillinger JB, Roberts GJ, Nabutovsky Y, Mittal S (June 2017). “Incidence and Time Course for Developing Heart Failure With High-Burden Right Ventricular Pacing”. Circ Cardiovasc Qual Outcomes. 10 (6). doi:10.1161/CIRCOUTCOMES.117.003564. PMID 28630373.
- ↑ Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO (January 2013). “2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society”. Circulation. 127 (3): e283–352. doi:10.1161/CIR.0b013e318276ce9b. PMID 23255456.
- ↑ Strasberg B, Kusniec J, Erdman S, Lewin RF, Arditti A, Sclarovsky S, Agmon J (July 1986). “Polymorphous ventricular tachycardia and atrioventricular block”. Pacing Clin Electrophysiol. 9 (4): 522–6. doi:10.1111/j.1540-8159.1986.tb06609.x. PMID 2426671.
- ↑ Tanaka Y, Yamabe H, Yamasaki H, Tsuda H, Nagayoshi Y, Kawano H, Kimura Y, Hokamura Y, Ogawa H (June 2009). “A case of reversible ventricular tachycardia and complete atrioventricular block associated with primary cardiac B-cell lymphoma”. Pacing Clin Electrophysiol. 32 (6): 816–9. doi:10.1111/j.1540-8159.2009.02372.x. PMID 19545348.
- ↑ Kosmidou I, Redfors B, Dordi R, Dizon JM, McAndrew T, Mehran R, Ben-Yehuda O, Mintz GS, Stone GW (May 2017). “Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial)”. Am. J. Cardiol. 119 (9): 1295–1301. doi:10.1016/j.amjcard.2017.01.019. PMID 28267964.
- ↑ Harikrishnan P, Gupta T, Palaniswamy C, Kolte D, Khera S, Mujib M, Aronow WS, Ahn C, Sule S, Jain D, Ahmed A, Cooper HA, Jacobson J, Iwai S, Frishman WH, Bhatt DL, Fonarow GC, Panza JA (December 2015). “Complete Heart Block Complicating ST-Segment Elevation Myocardial Infarction: Temporal Trends and Association With In-Hospital Outcomes”. JACC Clin Electrophysiol. 1 (6): 529–538. doi:10.1016/j.jacep.2015.08.007. PMID 29759406.
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
Related Chapters
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
